The global new drug delivery systems (NDDS) market is anticipated to grow at a CAGR of 21.6% during the forecast period (2024-2031). Nanomedicine plays a significant role in various areas of healthcare, including cancer treatment, diabetes management, pain management, neurological disorders, respiratory disorders, cardiovascular diseases, and infectious diseases. It offers targeted drug delivery, reduces systemic toxicity, and enhances the effectiveness of medications through the use of different drug delivery systems such as liposomal formulations, polymer-based nanoparticles, transdermal patches, inhalable formulations, and implantable devices.
Browse the full report description of “New Drug Delivery Systems (NDDS) Market Size, Share & Trends Analysis Report by Route of Administration (Oral Drug Delivery Systems (DDS), Injectable Drug Delivery Systems (DDS), Pulmonary Drug Delivery Systems (DDS), Transdermal Drug Delivery Systems (DDS), and Others ), and by Mode of NDDS (Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/ndds-market
These advancements in nanotechnology aim to improve patient outcomes and minimize adverse effects associated with traditional treatments. The market’s growth is attributed to the increasing demand for chronic diseases. The growth in chronic diseases needs improved drug delivery systems. NDDS has the potential to improve disease management by providing controlled and sustained drug release, that aligns with the demands of patients that require long-term medication therapy. For instance, in March 2022, Gufic Biosciences has launched indigenous New Drug Delivery System (NDDS) named Dual Chamber Bags (DCB).The most essential component of these Dual Chamber Bags is their ability to prevent contamination while additionally protecting the drug's potency and efficiency. The DCB closed system ensures that the product is appropriate and minimizes the possibility of contamination during handling.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2023-2031
• Segment Covered-
o By Route of Administration
o By Mode of NDDS
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Bayer AG, Boston Scientific Corp., Johnson & Johnson Services, Inc., and Merck KGaA, and others.
Key questions addressed by the report
Global New Drug Delivery Systems (NDDS) Market Report Segment
By Route of Administration
By Mode of NDDS
Global New Drug Delivery Systems (NDDS) Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ndds-market